» Articles » PMID: 15277517

Antizyme Targets Cyclin D1 for Degradation. A Novel Mechanism for Cell Growth Repression

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 Jul 28
PMID 15277517
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Overproduction of the ornithine decarboxylase (ODC) regulatory protein ODC-antizyme has been shown to correlate with cell growth inhibition in a variety of different cell types. Although the exact mechanism of this growth inhibition is not known, it has been attributed to the effect of antizyme on polyamine metabolism. Antizyme binds directly to ODC, targeting ODC for ubiquitin-independent degradation by the 26 S proteasome. We now show that antizyme induction also leads to degradation of the cell cycle regulatory protein cyclin D1. We demonstrate that antizyme is capable of specific, noncovalent association with cyclin D1 and that this interaction accelerates cyclin D1 degradation in vitro in the presence of only antizyme, cyclin D1, purified 26 S proteasomes, and ATP. In vivo, antizyme up-regulation induced either by the polyamine spermine or by antizyme overexpression causes reduction of intracellular cyclin D1 levels. The antizyme-mediated pathway for cyclin D1 degradation is independent of the previously characterized phosphorylation- and ubiquitination-dependent pathway, because antizyme up-regulation induces the degradation of a cyclin D1 mutant (T286A) that abrogates its ubiquitination. We propose that antizyme-mediated degradation of cyclin D1 by the proteasome may provide an explanation for the repression of cell growth following antizyme up-regulation.

Citing Articles

AZIN1 level is increased in medulloblastoma and correlates with c-Myc activity and tumor phenotype.

Sesen J, Martinez T, Busatto S, Poluben L, Nassour H, Stone C J Exp Clin Cancer Res. 2025; 44(1):56.

PMID: 39962590 PMC: 11831846. DOI: 10.1186/s13046-025-03274-1.


Protein degradation of antizyme depends on the N-terminal degrons.

Hsieh J, Leong P, Yang Y, Liu Y, Liu G, Hung H Protein Sci. 2024; 33(11):e5199.

PMID: 39473024 PMC: 11521938. DOI: 10.1002/pro.5199.


Disruption of cyclin D1 degradation leads to the development of mantle cell lymphoma.

Lu K, Zhang M, Qin H, Shen S, Song H, Jiang H Acta Pharm Sin B. 2024; 14(7):2977-2991.

PMID: 39027231 PMC: 11252481. DOI: 10.1016/j.apsb.2024.03.013.


Antizyme inhibitor family: biological and translational research implications.

Feng Q, Wang H, Shao Y, Xu X Cell Commun Signal. 2024; 22(1):11.

PMID: 38169396 PMC: 10762828. DOI: 10.1186/s12964-023-01445-1.


EPLIN-β is a novel substrate of ornithine decarboxylase antizyme 1 and mediates cellular migration.

Li D, Neo S, Gunaratne J, Sabapathy K J Cell Sci. 2023; 136(12).

PMID: 37325974 PMC: 10281260. DOI: 10.1242/jcs.260427.